Common use of Additional Grant to Pfizer Clause in Contracts

Additional Grant to Pfizer. Subject to the terms and conditions of this Agreement including in particular Section 6.9, Auxilium hereby grants to Pfizer during the Term an exclusive license or sublicense, as applicable, including the right to sublicense solely in accordance with Section 2.4.3, to use the Product Trademark and Product Trade Dress solely to the extent necessary to (i) Commercialize the Product in the Field in the Territory and (ii) Package and Label the Product for Development or Commercialization in the Field in the Territory. Auxilium hereby grants to Pfizer during the Term and from and after the expiration or termination of this Agreement, a non-exclusive, royalty-free, irrevocable, perpetual, worldwide license, with the right to sublicense, under any Joint Collaboration Patents for any and all uses; provided, that in the event of termination of this Agreement such license grant is subject to the exclusive license granted by Pfizer to Auxilium pursuant to Section 2.2.2(iii).

Appears in 2 contracts

Sources: Development, Commercialization and Supply Agreement (Auxilium Pharmaceuticals Inc), Development, Commercialization and Supply Agreement (Auxilium Pharmaceuticals Inc)